PET/MRI scan for finding liver cancer or spread
Part of Cancer, Digestive system clinical trials.
This study tests whether a combined PET and MRI scan (with contrast) can find malignant liver lesions more accurately than a standard PET/CT. If you have a known or suspected liver tumor, this scan might give your doctors clearer images to decide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be 18 years or older.
- You must have a suspected or known liver tumor or cancer that may have spread to the liver.
- You need to be able to lie still inside a PET/MRI machine (about 45–60 minutes).
- You cannot have had a bad allergic reaction to MRI contrast dye in the past.
- You cannot be pregnant or breastfeeding.
- You must not have severe heart, kidney, or advanced liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two advanced imaging techniques — a combined PET/MR scan and an enhanced MRI — to see which one better finds and shows liver tumors or cancer that has spread to the liver. If you have signs of a liver problem, this trial may help doctors get a clearer picture of your condition.
This study looks at how well special imaging scans (PET/CT or PET/MRI) work in adults with suspected or diagnosed liver cancer. It may help doctors better see the cancer and plan next steps.
This trial uses a special PET scan that targets a protein found in liver cancer cells. It aims to see if this new scan works better than an enhanced MRI to find liver cancer. If you have suspected or confirmed liver cancer, this study might help guide your care.
This study compares different scan types (MRI, CT, and two PET scans) in people with hepatocellular carcinoma (a primary liver cancer). It may help doctors figure out which scan gives the most useful information for diagnosis and treatment planning.
This trial studies how well a special imaging test (68Ga-FAPI PET/MRI) can detect and evaluate hepatocellular carcinoma (HCC), a type of liver cancer. It may help doctors confirm diagnosis and plan next steps by seeing how the cancer takes up the tracer.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
Hear when a new Liver Cancer, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.